# Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

> **NCT06754904** · NA · RECRUITING · sponsor: **D.J. (Dirk) Grünhagen** · enrollment: 213 (estimated)

## Conditions studied

- Melanoma, Skin

## Interventions

- **PROCEDURE:** Omitting TLND
- **PROCEDURE:** Index node procedure

## Key facts

- **NCT ID:** NCT06754904
- **Lead sponsor:** D.J. (Dirk) Grünhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-23
- **Primary completion:** 2027-04-01
- **Final completion:** 2032-04-01
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06754904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06754904, "Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06754904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*